Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001864441 | SCV002134875 | pathogenic | not provided | 2021-10-11 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ADGRV1-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ile3849Metfs*28) in the ADGRV1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADGRV1 are known to be pathogenic (PMID: 19357117, 22135276, 22147658, 26226137, 26667666, 30029497, 32467589). |
Fulgent Genetics, |
RCV005038406 | SCV005672721 | likely pathogenic | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2024-04-19 | criteria provided, single submitter | clinical testing |